Search results
Results from the WOW.Com Content Network
Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group of pharmaceuticals that are used to lower the level of lipids and lipoproteins, such as cholesterol, in the blood (hyperlipidemia). The American Heart Association recommends the descriptor ...
Cardiovascular agents are drugs used to treat diseases associated with the heart or blood vessels. These medications are available for purchase only with a physician’s prescription . They include, but are not limited to, drugs that target hypertension ( antihypertensives ), hyperlipidemia ( antihyperlipidemics ) and blood clotting (blood ...
Fenofibrate (sold under the brand name Tricor among others), is an oral medication of the fibrate class used to treat abnormal blood lipid levels. [3] It is less commonly used compared to statins because it treats a different type of cholesterol abnormality to statins.
[17] [18] The medication appears to work equally well regardless of sex, [19] although some sex-related differences in treatment response were described. [ 20 ] If there is an underlying history of cardiovascular disease, it has a significant impact on the effects of statin.
Pack extra medication in case a vial gets damaged in transit. If your compounded semaglutide is exposed to direct sunlight or high temperatures, or it’s frozen, you may have to throw it away ...
In combination with statin drugs, fibrates cause an increased risk of rhabdomyolysis, idiosyncratic destruction of muscle tissue, leading to kidney failure. The less lipophilic statins are less prone to cause this reaction, and are probably safer to be combined with fibrates than the more lipophilic statins are. Drug toxicity includes acute ...
Aspirin is an over-the-counter medication used for a variety of reasons, but particularly in heart attack and stroke prevention for older people. Aside from pain treatment, ...
The U.S. Food and Drug Administration (FDA) recently approved adding to Wegovy's label that the drug can also reduce the risk of heart events by 20% in people with obesity , for example.